Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real‐World Evidence

Journal:
Annals of Neurology
Published:
DOI:
10.1002/ana.78033
Affiliations:
1
Authors:
4
Go to article
Institutions Authors Share
University of California, San Francisco (UCSF), United States of America (USA)
4.000000
 1.00
Interested in Immunology?